AI
GTx Q3 Loss Narrows On Higher Revenues; Stock Surges On Tie Up With Merck [GTXI]
11/6/2007 11:09:55 AM Tuesday, GTx, Inc. (GTXI), a biopharmaceutical company, announced its third quarter financial results, posting a narrower loss compared to the year ago quarter, helped by increased revenues. Further, the company along with Merck has reached an accord to form a Global strategic collaboration for the development of novel investigational class of drugs to treat muscle loss and other musculoskeletal conditions. On the partnership news, GTx's stock surged and is currently trading above 9%.
11/6/2007 11:09:55 AM Tuesday, GTx, Inc. (GTXI), a biopharmaceutical company, announced its third quarter financial results, posting a narrower loss compared to the year ago quarter, helped by increased revenues. Further, the company along with Merck has reached an accord to form a Global strategic collaboration for the development of novel investigational class of drugs to treat muscle loss and other musculoskeletal conditions. On the partnership news, GTx's stock surged and is currently trading above 9%.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
